Holen Sie sich die Stockscreener-App
2.71
2.17%
-0.06
Handel nachbörslich:
2.71
Akebia Therapeutics Inc Aktie (AKBA) Neueste Nachrichten
Karyopharm Therapeutics (KPTI) Moves 27.9% Higher: Will This Strength Last? - Yahoo Finance
Goldman Sachs Group Inc. Grows Stock Holdings in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Market Review: Should value investors consider NRGD2025 Top Decliners & Fast Exit/Entry Strategy Plans - khodrobank.com
Options Flow: Can VIVS navigate macro headwindsMarket Performance Report & Technical Analysis for Trade Confirmation - khodrobank.com
Akebia Therapeutics extends loan agreement, receives $9.3M - MSN
Can Akebia Therapeutics Inc benefit from deglobalization2025 Biggest Moves & Risk Controlled Stock Pick Alerts - khodrobank.com
Aug Ideas: Is Akebia Therapeutics Inc attractive for institutional investorsEarnings Recap Report & Free Weekly Chart Analysis and Trade Guides - khodrobank.com
Akebia Therapeutics (NASDAQ:AKBA) Downgraded by Wall Street Zen to "Buy" - MarketBeat
Options Flow: Does Akebia Therapeutics Inc have strong fundamentalsMarket Performance Report & Consistent Income Trade Recommendations - خودرو بانک
Volume Report: What is Akebia Therapeutics Inc. s 5 year growth outlookMarket Sentiment Summary & High Conviction Investment Ideas - خودرو بانک
Trade Recap: Is Akebia Therapeutics Inc stock forming a cup and handleWeekly Trend Summary & Precise Trade Entry Recommendations - khodrobank.com
Woodline Partners LP Buys New Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Aug Outlook: Is Akebia Therapeutics Incs ROIC above industry averageInsider Buying & Real-Time Stock Entry Alerts - خودرو بانک
Aug Summary: Is Akebia Therapeutics Inc stock trending bullishWeekly Stock Report & Risk Controlled Daily Plans - khodrobank.com
Jobs Data: Is Akebia Therapeutics Inc forming a double bottomJuly 2025 Volume & Real-Time Market Sentiment Alerts - خودرو بانک
Exit Recap: Can Akebia Therapeutics Inc deliver consistent EPS growthPrice Action & Expert-Curated Trade Recommendations - khodrobank.com
Analyst Upgrade: Whats the beta of Akebia Therapeutics Inc stock2025 Major Catalysts & Weekly Top Gainers Trade List - خودرو بانک
Quarterly Earnings: Does ProShares Trust ProShares UltraShort Russell2000 have declining or rising EPSJuly 2025 Chart Watch & AI Based Trade Execution Alerts - خودرو بانک
What is Akebia Therapeutics Inc. s 5 year growth outlookJuly 2025 Institutional & Stepwise Trade Execution Plans - خودرو بانک
Weekly Trades: What is Fidelity National Financial Incs valuation compared to sectorShort Setup & Long-Term Safe Investment Plans - خودرو بانک
Market Leaders: Can Akebia Therapeutics Inc stock outperform in a bear market2025 Sector Review & Fast Exit and Entry Strategy Plans - خودرو بانک
Whats the beta of Akebia Therapeutics Inc stockJuly 2025 Patterns & AI Enhanced Market Trend Forecasts - khodrobank.com
Entry Recap: Is Akebia Therapeutics Inc a stock for growth or value investorsMarket Risk Summary & Fast Entry and Exit Trade Plans - خودرو بانک
Winners Losers: Is Akebia Therapeutics Inc. a strong candidate for buy and holdInflation Watch & Weekly High Return Forecasts - خودرو بانک
Jacobs Levy Equity Management Inc. Has $3.03 Million Stake in Akebia Therapeutics, Inc. $AKBA - MarketBeat
134,277 Shares in Akebia Therapeutics, Inc. $AKBA Purchased by Alyeska Investment Group L.P. - MarketBeat
Invesco Ltd. Purchases 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat
Individual Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) Market Cap Dropped by US$50m - 富途牛牛
Retail investors who have a significant stake must be disappointed along with institutions after Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) market cap dropped by US$50m - simplywall.st
MetLife Investment Management LLC Buys 14,134 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World
Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment By Investing.com - Investing.com Canada
Akebia at H.C. Wainwright: Strategic Growth in Anemia Treatment - Investing.com
Akebia Therapeutics Inc. Stock Poised for Technical ComebackWeekly Investment Recap & Free Expert Approved Momentum Trade Ideas - beatles.ru
Akebia outlines access to over 275,000 dialysis patients for Vafseo in Q4 as DaVita pilot launches - MSN
Does Akebia Therapeutics Inc. have pricing powerJuly 2025 Movers & High Accuracy Investment Entry Signals - beatles.ru
What are Akebia Therapeutics Inc.’s earnings expectationsMarket Volume Report & Consistent Income Trade Ideas - 뉴스영
Akebia Therapeutics (AKBA) Grants Stock Options to New Employees - MSN
Nantahala Capital Management LLC Invests $3.84 Million in Akebia Therapeutics, Inc. $AKBA - MarketBeat
Akebia Therapeutics, Inc. (NASDAQ:AKBA) most popular amongst individual investors who own 55% of the shares, institutions hold 43% - Yahoo Finance
Invesco Ltd. Acquires 139,957 Shares of Akebia Therapeutics, Inc. $AKBA - Defense World
How to interpret RSI for Akebia Therapeutics Inc. stockPortfolio Return Report & AI Enhanced Execution Alerts - Newser
Panic Selling: Is Akebia Therapeutics Inc. forming a bullish divergencePortfolio Gains Summary & Daily Stock Trend Watchlist - خودرو بانک
Can Akebia Therapeutics Inc. keep up with sector leadersTrade Analysis Summary & Scalable Portfolio Growth Methods - خودرو بانک
Is Akebia Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Setups & Growth Oriented Trade Recommendations - خودرو بانک
Biotech Movers: Akebia Soars on Expanded Partnership With Otsuka - TheStreet
Detecting support and resistance levels for Akebia Therapeutics Inc.July 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
Measuring Akebia Therapeutics Inc.’s beta against major indicesPortfolio Performance Summary & High Accuracy Buy Signal Tips - Newser
Wellington Management Group LLP Acquires 164,440 Shares of Akebia Therapeutics, Inc. $AKBA - MarketBeat
0.91%
2.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):